Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

292 ta ish

Ish: Nanoparticle-Based PCSK9 Inhibition in Viral Infections: Evaluating Clinical Limitations and Advancing Therapeutic Strategies

  1. The effect of surface charge on oral absorption of polymeric nanoparticles

    Xiao‐Jiao Du, Jilong Wang, Shoaib Iqbal +5

    Maqola20182 iqtibos
    ABI

  2. Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines

    Eugenia D. Namiot, Aleksandr V. Sokolov, Vladimir N. Chubarev +2

    Sharh maqola20232 iqtibos
    ABI

  3. Review of the efficacy of nanoparticle-based drug delivery systems for cancer treatment

    Karthikeyan Elumalai, Sivaneswari Srinivasan, Shanmugam Anandakumar

    Maqola20232 iqtibos
    ABI

  4. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

    Marianne Abifadel, Mathilde Varret, Jean‐Pierre Rabès +23

    Maqola20032 iqtibos
    ABI

  5. Sequence Variations in <i>PCSK9,</i> Low LDL, and Protection against Coronary Heart Disease

    Jonathan C. Cohen, Eric Boerwinkle, Thomas H. Mosley +1

    Maqola20062 iqtibos
    ABI

  6. The <i>PCSK9</i> gene R46L variant is associated with lower plasma lipid levels and cardiovascular risk in healthy U.K. men

    Mariléia Scartezini, Christina Hubbart, Ros Whittall +3

    Maqola20072 iqtibos
    ABI

  7. Advances in the Omicron variant development

    Antonio Vitiello, Francesco Ferrara, Amogh Auti +2

    Sharh maqola20222 iqtibos
    ABI

  8. Challenges associated with penetration of nanoparticles across cell and tissue barriers: A review of current status and future prospects

    Sutapa Barua, Samir Mitragotri

    Sharh maqola20142 iqtibos
    ABI

  9. The Future of Drug Delivery

    Jingjing Gao, Jeffrey M. Karp, Róbert Langer +1

    Maqola20232 iqtibos
    ABI

  10. A state-of-the-art review on the recent advances of niosomes as a targeted drug delivery system

    Saman Yasamineh, Pooneh Yasamineh, Hesam Ghafouri Kalajahi +8

    Sharh maqola20222 iqtibos
    ABI

  11. Nanotechnology-based approaches for targeted drug delivery for the treatment of respiratory tract infections

    Vasiliki Georgakopoulou, Petros Papalexis, Νικόλαος Τράκας

    Sharh maqola20242 iqtibos
    ABI

  12. Clinical Translation of Extracellular Vesicles

    Aayushi Ghodasara, Aun Raza, Joy Wolfram +2

    Maqola20232 iqtibos
    ABI

  13. SARS-CoV-2 Omicron variant: recent progress and future perspectives

    Yao Fan, Xiang Li, Lei Zhang +3

    Sharh maqola20222 iqtibos
    ABI

  14. Prevalence and predictors of dyslipidemia among HAART treated and HAART naive HIV positive clients attending Debre Tabor Hospital, Debre Tabor, Ethiopia

    Anemut Tilahun, Endeshaw Chekol Abebe, Awgchew Behaile Teklemaryam +10

    Maqola20222 iqtibos
    ABI

  15. Preclinical testing of antiviral siRNA therapeutics delivered in lipid nanoparticles in animal models – a comprehensive review

    Yusuf M. Idres, Adi Idris, Wenqing Gao

    Sharh maqola20252 iqtibos
    ABI

  16. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  17. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  18. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  19. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  20. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  21. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  22. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  23. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  24. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  25. Sarlavhasiz

    Boshqa1 iqtibos
    ABI